NCT00387426 2014-05-28Sunitinib in Treating Patients With Idiopathic MyelofibrosisNational Cancer Institute (NCI)Phase 2 Terminated14 enrolled 5 charts
NCT01426334 2014-04-02Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib MesylateNational Cancer Institute (NCI)Phase 1 Terminated4 enrolled
NCT00101088 2013-01-14Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous LeukemiaNational Cancer Institute (NCI)Phase 1 Terminated21 enrolled